Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

Our Experts

Andrew Aijian

Stephane Budel

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pre-due diligence research on a potential acquisition target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform

A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis

Target Identification

Clinical Diagnostics

IVDR Opportunity Assessment

A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help